Jesper Bøje Andersen

Jesper Bøje Andersen

Professor


  1. 2010
  2. Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma

    Lee, Y., Andersen, Jesper Bøje, Song, H., Judge, A. D., Seo, D., Ishikawa, T., Marquardt, J. U., Kitade, M., Durkin, M. E., Raggi, C., Woo, H. G., Conner, E. A., Avital, I., Maclachlan, I., Factor, V. M. & Thorgeirsson, S. S., 1 Nov 2010, In: Cancer Research. 70, 21, p. 8264-9 6 p.

    Research output: Contribution to journalJournal articlepeer-review

  3. An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

    Andersen, Jesper Bøje, Factor, V. M., Marquardt, J. U., Raggi, C., Lee, Y., Seo, D., Conner, E. A. & Thorgeirsson, S. S., 20 Oct 2010, In: Science Translational Medicine. 2, 54, p. 54ra77

    Research output: Contribution to journalJournal articlepeer-review

  4. Progenitor-derived hepatocellular carcinoma model in the rat

    Andersen, Jesper Bøje, Loi, R., Perra, A., Factor, V. M., Ledda-Columbano, G. M., Columbano, A. & Thorgeirsson, S. S., Apr 2010, In: Hepatology. 51, 4, p. 1401-9 9 p.

    Research output: Contribution to journalJournal articlepeer-review

  5. Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice

    Factor, V. M., Seo, D., Ishikawa, T., Kaposi-Novak, P., Marquardt, J. U., Andersen, Jesper Bøje, Conner, E. A. & Thorgeirsson, S. S., 2010, In: PLOS ONE. 5, 9

    Research output: Contribution to journalJournal articlepeer-review

ID: 93714085